2021
A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis
Psutka SP, Gulati R, Jewett MAS, Fadaak K, Finelli A, Legere L, Morgan TM, Pierorazio PM, Allaf ME, Herrin J, Lohse CM, Thompson R, Boorjian SA, Atwell TD, Schmit GD, Costello BA, Shah ND, Leibovich BC. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. European Urology 2021, 81: 576-585. PMID: 34862099, PMCID: PMC10351331, DOI: 10.1016/j.eururo.2021.11.002.Peer-Reviewed Original ResearchConceptsCancer-specific mortalityRenal cortical massesRadical nephrectomyPartial nephrectomyActive surveillancePersonalized treatment selectionClavien gradeRisk calculatorThermal ablationTreatment selectionEastern Cooperative Oncology Group performance statusClinical T1 renal massesSurgeon/hospital volumeHigh-volume referral centerInitial radical nephrectomyCharlson Comorbidity IndexCompeting-risks regressionConsecutive adult patientsGlomerular filtration rateClavien grade 3Risk of deathBody mass indexT1 renal massesRisk of mortalityClinical decision aid
2020
PD02-07 A NOVEL CLINICAL DECISION AID TO SUPPORT PERSONALIZED TREATMENT SELECTION FOR PATIENTS WITH RENAL CORTICAL MASSES ≤7 CM: RESULTS FROM A MULTI-INSTITUTIONAL COMPETING RISKS ANALYSIS INCLUDING PERFORMANCE STATUS AND COMORBIDITY
Psutka* S, Gulati R, Jewett M, Fadaak K, Finelli A, Legere L, Morgan T, Pierorazio P, Allaf M, Herrin J, Lohse C, Thompson R, Boorjian S, Atwell T, Schmit G, Costello B, Shah N, Leibovich B. PD02-07 A NOVEL CLINICAL DECISION AID TO SUPPORT PERSONALIZED TREATMENT SELECTION FOR PATIENTS WITH RENAL CORTICAL MASSES ≤7 CM: RESULTS FROM A MULTI-INSTITUTIONAL COMPETING RISKS ANALYSIS INCLUDING PERFORMANCE STATUS AND COMORBIDITY. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000822.07.Peer-Reviewed Original ResearchA novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity.
Psutka S, Gulati R, Jewett M, Fadaak K, Finelli A, Morgan T, Pierorazio P, Allaf M, Herrin J, Lohse C, Thompson R, Boorjian S, Atwell T, Schmit G, Costello B, Legere L, Shah N, Leibovich B. A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity. Journal Of Clinical Oncology 2020, 38: 610-610. DOI: 10.1200/jco.2020.38.6_suppl.610.Peer-Reviewed Original ResearchCancer-specific mortalityRenal cortical massesCharlson Comorbidity IndexPerformance statusActive surveillancePersonalized treatment selectionCortical massTreatment selectionThermal ablationContemporary multi-institutional cohortTreatment-specific probabilitiesECOG performance statusTreatment-associated complicationsMulti-institutional cohortCause of deathClinical decision aidCause of mortalityCause mortalityComorbidity indexEligible patientsPatient characteristicsComplication ratePatient ageRadiological featuresComplication risk